Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Colorectal cancer statistics, 2020
2020 Standout
Colorectal cancer statistics, 2023
2023 Standout
Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion
2017
mRECIST for HCC: Performance and novel refinements
2020
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis
2016
Left-Liver Hypertrophy After Therapeutic Right-Liver Radioembolization Is Substantial but Less Than After Portal Vein Embolization
2013
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
2021
Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis
2017
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Treatments for colorectal liver metastases: A new focus on a familiar concept
2016
Pyroptosis: mechanisms and diseases
2021 Standout
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018
Diagnostic Accuracy of Computer Tomography Angiography and Magnetic Resonance Angiography in the Stenosis Detection of Autologuous Hemodialysis Access: A Meta-Analysis
2013
Global burden of liver disease: 2023 update
2023 Standout
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Erratum to: Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis
2017
Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures
2021
Validation of the Hong Kong Liver Cancer Staging System in Determining Prognosis of the North American Patients Following Intra-arterial Therapy
2016
Hepatocellular carcinoma
2022 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Hepatocellular Carcinoma
2019 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma
2019
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Colorectal cancer statistics, 2017
2017 Standout
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma
2016
Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series
2017
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference
2020
Transarterial Chemoembolization and Radioembolization
2014
Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
2021
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma
2015
Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study
2021
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
2020 Standout
Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma
2014
Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta‐analysis
2017
Works of Ryan Hickey being referenced
Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization
2017
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
2016
Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma
2018
Time-resolved MR Angiography with Generalized Autocalibrating Partially Parallel Acquisition and Time-resolved Echo-sharing Angiographic Technique for Hemodialysis Arteriovenous Fistulas and Grafts
2006
Radiation lobectomy: Time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection
2013
Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib
2013
Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization
2013
Locoregional Therapy of Hepatocellular Carcinoma
2015
Independent Analysis of Albumin-Bilirubin Grade in a 765-Patient Cohort Treated with Transarterial Locoregional Therapy for Hepatocellular Carcinoma
2016
Unresectable Solitary Hepatocellular Carcinoma Not Amenable to Radiofrequency Ablation: Multicenter Radiology-Pathology Correlation and Survival of Radiation Segmentectomy
2014
Radioembolization for hepatocellular carcinoma: Statistical confirmation of improved survival in responders by landmark analyses
2017
Comparative Study of Staging Systems for Hepatocellular Carcinoma in 428 Patients Treated with Radioembolization
2014